Novo CEO pressed by Senate to cut prices of being overweight, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would contemplate new talks with insurers with regard to the record rates of Wegovy and copyright whenever they pledge to help keep the medicines on their own https://kethek.com/